Jump to main content
Jump to site search

Issue 33, 2015
Previous Article Next Article

Scaffold-hopping and hybridization based design and building block strategic synthesis of pyridine-annulated purines: discovery of novel apoptotic anticancer agents

Author affiliations

Abstract

A set of novel pyridine-annulated analogs of purinones, adenines and their oxo/thio congeners, xanthines, guanines, and purine-2,4-diamines as potential anticancer agents was considered based on the scaffold-hopping and hybridization of known anticancer agents/drugs, purine derivatives and our recently developed imidazo-pyridine derivatives. Towards the synthesis of these compounds, a new approach involving a convenient preparation of 3-amino-2-carboxyethyl substituted imidazo[1,2-a]-pyridine and its use as a building block for the construction of fused rings was developed. The approach enabled the preparation of a number of compounds with relevant substitutions for each class. Several of pyridine-annulated adenine and its oxo/thio analogs, xanthine and purine-2,4-diamine were found to possess significant anticancer activities in kidney cancer cells and relatively less cytotoxicity to normal cells. They were relatively more active than the anticancer drugs etoposide and doxorubicin. A representative pyridine-annulated adenine derivative compound(22) was found to exert significant apoptosis.

Graphical abstract: Scaffold-hopping and hybridization based design and building block strategic synthesis of pyridine-annulated purines: discovery of novel apoptotic anticancer agents

Back to tab navigation

Supplementary files

Publication details

The article was received on 02 Jan 2015, accepted on 03 Mar 2015 and first published on 04 Mar 2015


Article type: Paper
DOI: 10.1039/C5RA00052A
Author version
available:
Download author version (PDF)
RSC Adv., 2015,5, 26051-26060

  •   Request permissions

    Scaffold-hopping and hybridization based design and building block strategic synthesis of pyridine-annulated purines: discovery of novel apoptotic anticancer agents

    V. Chaudhary, S. Das, A. Nayak, S. K. Guchhait and C. N. Kundu, RSC Adv., 2015, 5, 26051
    DOI: 10.1039/C5RA00052A

Search articles by author

Spotlight

Advertisements